Stanford Launches Program to Combat Antibiotic Resistance with Phage Therapy

Stanford University has established The Center for Phage Pharmaceuticals, backed by a substantial grant, to advance the clinical use of bacteriophages. These viruses naturally target and eliminate bacteria, presenting a potent new strategy against infections resistant to antibiotics. The program aims to accelerate research into this promising alternative treatment.